Highlights
Signed an agreement with Medicines for Malaria Venture (MMV) to provide MMV with access to the Pfizer library of novel chemical entities to screen for compounds that could be developed into new treatments for malaria.
Obtained first accreditation in the pharmaceutical industry by the Association for the Accreditation of Human Research Protection Program (AAHRP) for protection of human rights in clinical research.
Registered over 1,183 trials to www.clinicaltrials.gov. In addition, 885 summaries of trial results have been posted on www.clinicalstudyresults.org.
As advances in medical care help more and more people live longer lives, the need for new medicines to keep people healthy continues to grow. Pfizer researchers and scientists are working to discover and develop new ways to treat and prevent life-threatening and debilitating illnesses like Alzheimer's disease and cancer, as well as to improve wellness and quality of life across a range of therapeutic areas. At Pfizer, we are focusing on developing treatments for unmet medical needs inspired by a single goal: patient health. This is why we are dedicated to developing promising new medicines to prevent and treat the world's most serious diseases. We believe that from progress comes hope, and the promise of a healthier world.
Pfizer's research & development teams are focused on nine therapeutic and disease areas that span a broad range of medical needs. Our current pipeline reflects a therapeutic-area focus with 100 programs in Phase I through Phase III. From March 2008 to September 2008, 21 programs advanced in the pipelineııı12 of them in the identified high-priority disease areas of diabetes, oncology, inflammation/immunology, Alzheimer's disease, psychoses and pain.
Pfizer's recently established business unitsıııfor Primary Care, Specialty, Oncology, Established Products, and Emerging Marketsıııare designed to respond to customers' and patients' changing needs and to ensure the alignment of research and development activities with these needs.
Read more about Research and Development in PDF